共 9 条
[1]
[2]
乌司他丁治疗重症脓毒症患者的临床疗效分析[J] 陈朴 中国实用内科杂志 2005, 09
[3]
[4]
[5]
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J] R. Phillip Dellinger;Jean M. Carlet;Henry Masur;Herwig Gerlach;Thierry Calandra;Jonathan Cohen;Juan Gea-Banacloche;Didier Keh;John C. Marshall;Margaret M. Parker;Graham Ramsay;Janice L. Zimmerman;Jean-Louis Vincent;M. M. Levy Intensive Care Medicine 2004,
[6]
Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis[J] Axel Nierhaus;Barbara Montag;Nicole Timmler;Daniel P. Frings;Kai Gutensohn;Roman Jung;Claus G. Schneider;Werner Pothmann;Anne K. Brassel;Jochen Schulte am Esch Intensive Care Medicine 2003,
[7]
CD64 surface expression on neutrophils is transiently upregulated in patients with septic shock[J] Guenther Fischer;Elisabeth Schneider;Lyle L. Moldawer;Christian Karcher;Eberhard Barth;Heidemarie Suger-Wiedeck;Michael Georgieff;Manfred Weiss Intensive Care Medicine 2001,
[8]
Clinical trials of mediator-directed therapy in sepsis: what have we learned?[J] J. C. Marshall Intensive Care Medicine 2000,
[9]
Monocyte deactivation-rationale for a new therapeutic strategy in sepsis[J] Intensive Care Medicine 1996,

